Interim Ultimate Fighting Championship (UFC) Light Heavyweight champion, Jon Jones, failed his UFC 200 pre-fight drug test because he was trying to enhance his erections, according to Middleweight champion Michael Bisping on a recent episode of MMA on SiriusXM. How "The Count" obtained confidential medical information from United States Anti-Doping Agency (USADA) -- the independent administrator of UFC's Anti-Doping Policy -- about Jones' penis is unclear.

Then again, it seems as though company President Dana White shares similar access, so perhaps it isn't really all that confidential.

"It turns out Jon Jones didn’t take the estrogen blockers or whatever it was and, therefore, he may be coming back sooner rather than later," Bisping said. "I hear that the supplement in question — and it’s not even a supplement — was a sex aid, Cialis, but it was a generic version — it wasn’t the brand name. It apparently has estrogen blockers in it. That’s what he took and he’s maybe just looking at a little slap on the wrist."

The moral of the story? Don't go generic ... ever.

Jones -- who missed out on an "eight-figure" payday when the failed test triggered his removal from the historic main event opposite Daniel Cormier -- is facing a two-year ban from the sport. However, he recently announced that he could return to the Octagon sooner than later after a recent development. If Nevada State Athletic Commission (NSAC) believes the latest sex pills defense, Jones could possibly earn a reduced sentence or nothing at all if he disclosed the medication on his medical form.

Teflon Jon strikes again?